Department of Internal Medicine (I), Osaka Medical College, Japan.
Division of Surgical Pathology, Osaka Medical College, Osaka, Japan.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):103-7. doi: 10.1177/039463201402700113.
We present the case of a 64-year-old male with painful swelling of the bilateral testes and epididymides, high fever, leukocytosis, and an elevated C-reactive protein (CRP) level. This is the first case report of testicular diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) immunostained for multiple cytokines and their receptors, which clearly demonstrates that tumor cells express multiple cytokines [interleukin-6 (IL-6) and granulocyte colony-stimulating factor (G-CSF)] and their receptors [IL-6 receptor (IL-6R) and G-CSF receptor (G-CSFR)]. The clinical course showed that the reduction in tumor size was accompanied by a corresponding improvement in clinical symptoms and peripheral blood findings. Such clinical investigation may lead clinicians to misdiagnose inflammatory disease rather than neoplastic disease. Recognizing this paraneoplastic phenomenon associated with some cases of testicular DLBCL, NOS is important. In addition, this case suggests that the growth of tumor cells may be promoted through autocrine mechanisms of IL-6 and G-CSF, which are produced by tumor cells. The possibility that these cytokines can be produced by tumor cells and can accelerate tumor proliferation should be considered to be a cause of severe clinical symptoms, an aggressive clinical course, and an indication of the necessity of treatment. Certain cytokines may be used as tumor markers in some cases of DLBCL, NOS.
我们报告了一例 64 岁男性,双侧睾丸和附睾出现疼痛性肿胀、高热、白细胞增多和 C 反应蛋白(CRP)水平升高。这是首例免疫组化染色显示多种细胞因子及其受体的睾丸弥漫性大 B 细胞淋巴瘤,非特指型(DLBCL,NOS)的病例报告,明确显示肿瘤细胞表达多种细胞因子[白细胞介素 6(IL-6)和粒细胞集落刺激因子(G-CSF)]及其受体[IL-6 受体(IL-6R)和 G-CSF 受体(G-CSFR)]。临床过程表明,肿瘤体积缩小伴随着临床症状和外周血发现的相应改善。这种临床研究可能导致临床医生误诊为炎症性疾病而不是肿瘤性疾病。认识到与一些睾丸 DLBCL,NOS 相关的这种副瘤现象很重要。此外,该病例提示肿瘤细胞可能通过肿瘤细胞产生的 IL-6 和 G-CSF 的自分泌机制促进肿瘤细胞的生长。应考虑这些细胞因子可能由肿瘤细胞产生并加速肿瘤增殖,这是导致严重临床症状、侵袭性临床病程以及需要治疗的原因之一。在某些情况下,某些细胞因子可作为 DLBCL,NOS 的肿瘤标志物。